Royal Bank of Canada
FURX

Royal Bank of Canada’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Royal Bank of Canada’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-39
Closed -$4K – 6393
2014
Q2 		$4K Buy
39
+37
+1,850% +$3.63K ﹤0.01% 5641
2014
Q1 		$0 Hold
2
– – ﹤0.01% 6405
2013
Q4 		$0 Sell
2
-43
-96% -$1.77K ﹤0.01% 6459
2013
Q3 		$2K Sell
45
-322
-88% -$13.3K ﹤0.01% 5921
2013
Q2 		$13K Buy
+367
New +$12.9K ﹤0.01% 5196

Royal Bank of Canada's FURX Position: Q3 2014 in Review

Royal Bank of Canada sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 39 shares — an estimated $4K sold.

Royal Bank of Canada first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $13K in Q2 2013. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Royal Bank of Canada reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 39 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $4K.
  • Royal Bank of Canada first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Royal Bank of Canada's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $13K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Royal Bank of Canada's 13F filing for Q3 2014, filed 14 Nov 2014.